Preclinical Imaging Market Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Forecast Till 2027

Preclinical Imaging Market Scenario

Preclinical imaging market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.01 billion in 2017 and is projected to grow at a CAGR of 6.3% over the forecast period.

The factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical research are expected to propel the growth of the market. However, strict regulations in preclinical research and high installation and operational costs associated with preclinical imaging modalities hamper the market growth over the forecast period.

Segmentation

The preclinical imaging market has been segmented into modality, reagent, and region.

Based on modality, market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging system, and magnetic particle imaging systems. The optical imaging systems segment is expected to account for the largest share segment of the market in 2017.

Based on reagent, preclinical imaging market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. The preclinical optical imaging reagents segment is expected to account for the largest share segment of the market in 2017.

The preclinical imaging market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.

The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The preclinical imaging market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The preclinical imaging market in the Middle East & Africa segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the preclinical imaging market owing to a well-established player, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.

Europe is expected to hold the second largest position in the market. The market growth in this region is attributed to increasing funding to support preclinical researches.

The preclinical imaging market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the preclinical imaging market.

Market of Preclinical Imaging, by Modality

• Optical Imaging Systems




• Bioluminescence/Fluorescence Imaging Systems


• Standalone Fluorescence Imaging Systems


• Optical + X ray/ Optical + CT systems




• Nuclear Imaging Systems




• Micro-PET Systems


• Micro-Spect Systems


• Trimodality (Spect/PET/CT) Systems




• Micro-MRI


• Micro-Ultrasound


• Micro-CT


• Photoacoustic Imaging System


• Magnetic Particle Imaging Systems

Market of Preclinical Imaging, by Reagent

• Preclinical Optical Imaging Reagents




• Bioluminescent Imaging Reagents


• Fluorescent Imaging Reagents




• Preclinical Nuclear Imaging Reagents




• Preclinical PET Tracers


• Preclinical Spect Probes




• Preclinical MRI Contrast Agents


• Preclinical Ultrasound Contrast Agents


• Preclinical CT Contrast Agents

Market of Preclinical Imaging, by Region

• Americas




• North America




• US


• Canada




• South America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK




• Rest of Western Europe


• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• The Middle East & Africa




• Middle East


• Africa

Market of Preclinical Imaging, by Key Players

• Bruker Corporation (US)


• MR Solutions (UK)


• PerkinElmer (US)


• Fujifilm Holdings Corporation (Japan)


• Milabs B.V. (The Netherlands)


• Mediso Ltd. (Hungary)


• Miltenyi Biotec GmbH (Germany)


• LI-COR, Inc. (US)


• Aspect Imaging (Israel)


• Trifoil Imaging (US)

Intended Audience

• Preclinical Imaging Manufacturers and vendors


• Research organization and CRO


• Various research and consulting firms

Report Scope:

Report Attribute/Metric	Details
Market Size	2027: Significant Value
CAGR	6.3% (2018-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product and Reagent
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Aspect Imaging (Israel), Trifoil Imaging (US)
Key Market Opportunities	Technological advancements in the field of molecular imaging
Key Market Drivers	Increasing market demand for non-invasive small-animal imaging techniques Increasing funding to support preclinical researches

Frequently Asked Questions (FAQ) :

---